| 1 |
34983944 | SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages. | 2022 Feb |
1 |
| 2 |
35547841 | Adsorption of Pulmonary and Exogeneous Surfactants on SARS-CoV-2 Spike Protein. | 2022 May 4 |
1 |
| 3 |
32511366 | The role of high cholesterol in age-related COVID19 lethality. | 2021 Jun 28 |
1 |
| 4 |
34522180 | Possible mechanisms of cholesterol elevation aggravating COVID-19. | 2021 |
2 |
| 5 |
34975904 | Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry. | 2021 |
1 |
| 6 |
32457038 | Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity. | 2020 Jul |
1 |
| 7 |
32570882 | Cholesterol in Relation to COVID-19: Should We Care about It? | 2020 Jun 18 |
2 |
| 8 |
32817933 | Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry. | 2020 Oct 30 |
2 |
| 9 |
33363465 | MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics. | 2020 |
1 |
| 10 |
22227126 | The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. | 2012 Mar 15 |
1 |
| 11 |
18279660 | Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. | 2008 May 2 |
1 |
| 12 |
18814896 | Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. | 2008 Nov 25 |
3 |
| 13 |
8767468 | ACAT/CEH and ACEH/LAL: two key enzymes in hepatic cellular cholesterol homeostasis and their involvement in genetic disorders. | 1996 Jun |
1 |